Impact of an anti-inflammatory diet on patients with inflammatory bowel disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of an anti-inflammatory diet (AID) on patients diagnosed with inflammatory bowel disease (IBD). It involves a randomized controlled trial with 66 participants, who are divided into an experimental group receiving dietary intervention and a control group following standard care. The intervention lasts for 8 weeks, during which various inflammatory indicators and quality of life metrics are assessed before and after the dietary changes. The study aims to promote the use of AID in IBD management and explore new treatment strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Diagnosis of inflammatory bowel disease, the diagnostic criteria refer to the 2018 revised Consensus opinion on the diagnosis and treatment of inflammatory bowel disease;
2. The patient has clear consciousness and certain understanding, language expression and writing ability;
3. Patients participated in this study knowingly and voluntarily;
4. At least 18 years old.

Exclusion Criteria:

1. cognitive impairment, mental illness, accompanied by mental disorders;
2. Alcohol and drug abusers.
3. The patient could not participate in the researcher due to the deterioration of the condition;
4. Patients who voluntarily quit due to other reasons;
5. Those who did not complete the assessment scale during the experiment.

Where it's running

• The Fourth Affiliated Hospital of Zhejiang University School of Medicine
  Yiwu, Zhejiang, China Recruiting

Study contacts

• Principal investigator: Xia Qian, BA — The Fourth Affiliated Hospital of Zhejiang University School of Medicine
• Study coordinator: Xia Qian, BA
• Email: 1632936247@qq.com
• Phone: 15968110117

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-Term Guselkumab Use in Adults with Inflammatory Bowel Disease

  This study looks at how long adults with Crohn's disease or ulcerative colitis stay on guselkumab in real-world care.

  Recruiting Janssen Research & Development, LLC · Amiens · NCT07822529

• Intestinal ultrasound-guided management for inflammatory bowel disease

  This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.

  Recruiting Mahidol University · Bangkok · NCT07775352

• Resting energy use in kids with inflammatory bowel disease

  This multicenter study will test the resting energy expenditure of children aged 6–17 with new IBD diagnoses to see how it relates to disease activity and treatment.

  Recruiting Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Alessandria, Piedmont · NCT07670975

• Active video education by disease subtype to improve bowel prep before colonoscopy

  We’re testing whether adding subtype-specific video education to standard prep improves bowel cleanliness in adults with IBD undergoing colonoscopy.

  Recruiting at 12 sites Xijing Hospital of Digestive Diseases · Beijing, BeijingBeijing and 11 other locations · NCT07582731

• Intestinal ultrasound to predict relapse in Crohn's disease patients in deep remission.

  This project will try to see if a noninvasive transabdominal ultrasound can predict relapses in adults with Crohn's disease who are currently in deep remission.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07539727

• Ath-063: Testing a new treatment for moderately to severely active ulcerative colitis in patients who have tried other biologics

  This study tests ATH-063 to see if it helps people with moderate to severe ulcerative colitis who did not respond to or relapsed after prior biologic therapy.

  Recruiting at 4 sites Phase 2 Athos Therapeutics Inc · Miami, Florida and 3 other locations · NCT07513181

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.